Related Experiment Video

Updated: Dec 26, 2025

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

785

Non-FDA-Reviewed Imported European Formula Use Among Parents in Urban Pediatric Private Practice

Nan Du1, Dina M DiMaggio2, Jamila K Williams2

  • 1Yale University, New Haven, CT, USA.

Clinical Pediatrics
|March 10, 2020
PubMed

Insights

Many parents are using imported European infant formulas, believing they have better ingredients. Pediatricians must educate families on the safety and risks of these products.

Area of Science:

  • Pediatric Nutrition
  • Consumer Health

Background:

  • The American Academy of Pediatrics issued a warning in 2018 regarding the rise in imported infant formula usage.
  • Concerns exist regarding the safety and regulation of formulas not approved by the FDA.

Purpose of the Study:

  • To evaluate the prevalence of imported European infant formula use among parents in an urban private pediatric practice.
  • To understand parental motivations and information sources for using these formulas.

Main Methods:

  • An anonymous survey was administered to parents at well-child visits in an urban private pediatric practice.
  • Data was collected from November 2017 to March 2018 from 552 eligible respondents.

Main Results:

  • 20% of parents using formula reported using imported European brands.
  • Holle was the most common brand (33%), with 72% purchased via third-party web vendors.
  • Parents cited perceived superior ingredients as the primary reason for use.

Conclusions:

  • A significant percentage of parents are using imported European infant formulas, often sourced online.
  • There is a critical need for pediatricians to be informed about these products to provide adequate guidance on safety and appropriate use.
  • Enhanced pediatrician awareness and patient education are crucial for addressing parental concerns and ensuring infant safety.

Keywords:
European UnionFood and Drug AdministrationInfant Formula Actimported infant formulainfant nutrition

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K
Probiotic Studies in Neonatal Mice Using Gavage10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

20.5K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
182
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
185
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
198
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
143
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
156
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K